Skip to main content
. 2020 Nov 19;5(6):e001021. doi: 10.1136/esmoopen-2020-001021

Table 4.

Symptom description by tobacco consumption in non-small cell lung cancer

Symptoms at diagnosis* Never smokers† Ex-smokers† Current smokers† P trend
Cough 387 (34.1) 1310 (31.7) 1099 (34.5) 0.163
Pain 318 (28.0) 990 (24.0) 1008 (31.6) <0.001
Dyspnoea 330 (29.1) 1014 (24.5) 823 (25.8) 0.365
Haemoptysis 70 (6.2) 511 (12.4) 389 (12.2) <0.001
Weight loss 223 (19.7) 678 (16.4) 842 (26.4) <0.001
Anorexia 66 (5.8) 185 (4.5) 226 (7.1) 0.001
Asthenia 114 (10.1) 315 (7.6) 331 (10.4) 0.024
Superior vena cava syndrome 3 (0.3) 6 (0.1) 15 (0.5) 0.039
Aphonia or voice alterations 331 (2.7) 100 (2.4) 104 (3.3) 0.085
Number of symptoms‡
0
1
2
3
4 or more
341 (30.1)
252 (31.0)
236 (20.8)
127 (11.2)
78 (6.9)
1531 (37.0)
1121 (27.1)
812 (19.6)
427 (10.3)
242 (5.8)
879 (27.6)
887 (27.8)
694 (21.8)
454 (14.2)
272 (8.4)
<0.001
0.263
0.113
<0.001
<0.001

*Percentages calculated as a total of the sample.

†Never smoker: participant smoked less than 100 cigarettes in lifetime. Ex-smoker: stopped smoking more than 1 year before diagnosis. Current smoker: declared smoking during the year before diagnosis. Eighty-nine participants had unknown tobacco consumption.

‡Totals calculated for each smoking category.